scispace - formally typeset
Open AccessJournal ArticleDOI

Rethinking ovarian cancer: recommendations for improving outcomes

Reads0
Chats0
TLDR
Nine major recommendations that should be taken to improve the outcome for women with ovarian cancer are outlined in this Opinion article.
Abstract
There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to improve the outcome for women with ovarian cancer. Nine major recommendations are outlined in this Opinion article.

read more

Content maybe subject to copyright    Report

Citations
More filters
Dissertation

Detection of Lysophosphatidic Acid in Serum; Towards a Cost Effective Test for Ovarian Cancer

De La Franier, +1 more
TL;DR: There are currently no low cost or easy to perform blood tests for LPA, preventing its use as a general test that can be performed at yearly physicals, but there is a duel protein system comprised of Gelsolin and Actin which can be used to develop a low cost blood test for the marker.
Dissertation

Mainstreamed genetic testing in ovarian cancer : a case study of BRCA1/2 tumour testing

TL;DR: While MTT appears to have little psychosocial impact, poor understanding of the distinction between germline and somatic mutations indicates the need for improved communication and information provision in OC.
Journal ArticleDOI

Role of Nanotechnology in Cancer Diagnostics

TL;DR: This work has defined at molecular level a high similarity between basal like breast cancer and serious ovarian cancer which includes widespread genomic instability, gene alterations, and mRNA expression implying common biomarkers and therapeutic targets.
Journal ArticleDOI

Characterization and clinical significance of the CADM1/HER2/STAT3 axis in serous ovarian tumors.

TL;DR: In this article, the cell adhesion molecule 1 (CADM1)/signal transducer and activator of transcription 3 (STAT3)/human epidermal growth factor receptor 2 (HER2) axis was characterized in patients with serous cystadenoma, SBT, LGSC, and HGSC.
References
More filters
Journal ArticleDOI

Cancer-related inflammation.

TL;DR: The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
Journal ArticleDOI

Integrated genomic analyses of ovarian carcinoma

Debra A. Bell, +285 more
- 30 Jun 2011 - 
TL;DR: It is reported that high-grade serous ovarian cancer is characterized by TP53 mutations in almost all tumours (96%); low prevalence but statistically recurrent somatic mutations in nine further genes including NF1, BRCA1,BRCA2, RB1 and CDK12; 113 significant focal DNA copy number aberrations; and promoter methylation events involving 168 genes.

Integrated genomic analyses of ovarian carcinoma

Daphne W. Bell, +261 more
TL;DR: The Cancer Genome Atlas project has analyzed messenger RNA expression, microRNA expression, promoter methylation and DNA copy number in 489 high-grade serous ovarian adenocarcinomas and the DNA sequences of exons from coding genes in 316 of these tumours as mentioned in this paper.
Journal ArticleDOI

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

TL;DR: The presence of intratumoral T cells correlates with improved clinical outcome in advanced ovarian carcinoma and was associated with increased expression of interferon-gamma, interleukin-2, and lymphocyte-attracting chemokines within the tumor.
Related Papers (5)

Integrated genomic analyses of ovarian carcinoma

Debra A. Bell, +285 more
- 30 Jun 2011 -